SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-146396
Filing Date
2021-12-03
Accepted
2021-12-03 17:01:23
Documents
1
Period of Report
2021-12-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2134490-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2134490-1_4seq1.xml 4 7606
  Complete submission text file 0001104659-21-146396.txt   8918
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address
Korbel Gregory Alan (Reporting) CIK: 0001789032 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 211470860